Stock listing
Polypeptide Group Ag
Selected listing: A3CNHV · LS · EUR · DE
Polypeptide Group Ag (Lang & Schwarz: A3CNHV), Health Technology. Latest release Apr 8, 2026: PolyPeptide announces results of the annual General Meeting 2026.
- Ticker
- Lang & Schwarz: A3CNHV
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- Lang & Schwarz
- Currency
- EUR
About Polypeptide Group Ag
The company specializes in the development and manufacturing of peptide-based therapeutics. With a strong presence in the pharmaceutical industry, Polypeptide Group AG focuses on delivering innovative solutions to meet the needs of its clients.
Latest news from Polypeptide Group Ag
PolyPeptide announces results of the annual General Meeting 2026
April 8, 2026
PolyPeptide strengthens financing structure through expansion of existing credit facility
March 19, 2026
PolyPeptide publishes invitation to the annual General Meeting 2026
March 17, 2026
PolyPeptide delivers strong revenue growth and marked improvement in profitability
March 12, 2026
PolyPeptide successfully closes financial year 2025 with strong revenue growth and marked improvement in profitability
January 19, 2026
Research Polypeptide Group Ag
Polypeptide Group Ag company profile
View the public company page for Polypeptide Group Ag on 6ix.
Polypeptide Group Ag news
Read company news and market updates connected to Polypeptide Group Ag.
Polypeptide Group Ag investor events
Find investor webinars, events, and replay context for Polypeptide Group Ag.
Alternate listings
PPGN:SIX
CH · CHF
Alternate listing for Polypeptide Group Ag; the primary context on this page is A3CNHV:LS.
0AAJ:LSE
GB · CHF
Alternate listing for Polypeptide Group Ag; the primary context on this page is A3CNHV:LS.
8H0:GETTEX
DE · EUR
Alternate listing for Polypeptide Group Ag; the primary context on this page is A3CNHV:LS.
8H0:SWB
DE · EUR
Alternate listing for Polypeptide Group Ag; the primary context on this page is A3CNHV:LS.
8H0:TRADEGATE
DE · EUR
Alternate listing for Polypeptide Group Ag; the primary context on this page is A3CNHV:LS.
PLYGF:OTC
US · USD
Alternate listing for Polypeptide Group Ag; the primary context on this page is A3CNHV:LS.
PPGNZ:AQUISUK
GB · CHF
Alternate listing for Polypeptide Group Ag; the primary context on this page is A3CNHV:LS.
8H0:FWB
DE · EUR
Alternate listing for Polypeptide Group Ag; the primary context on this page is A3CNHV:LS.
A3CNHV:LSX
DE · EUR
Alternate listing for Polypeptide Group Ag; the primary context on this page is A3CNHV:LS.
8H0:BX
CH · CHF
Alternate listing for Polypeptide Group Ag; the primary context on this page is A3CNHV:LS.
PPGNZ:TURQUOISE
GB · CHF
Alternate listing for Polypeptide Group Ag; the primary context on this page is A3CNHV:LS.
8H0:DUS
DE · EUR
Alternate listing for Polypeptide Group Ag; the primary context on this page is A3CNHV:LS.